CN Patent

CN103664836B — 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法

Assigned to Qilu (linyi) Pharmaceutical Co Ltd · Expires 2016-04-20 · 10y expired

What this patent protects

本发明属于医药化工领域，具体涉及一种7β,10β-二甲氧基多西紫杉醇的氘代丙酮合物晶型A及其制备方法，所述的7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A具有良好的稳定性，并且在乙醇中具有较好的溶解性和溶解速度。

USPTO Abstract

本发明属于医药化工领域，具体涉及一种7β,10β-二甲氧基多西紫杉醇的氘代丙酮合物晶型A及其制备方法，所述的7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A具有良好的稳定性，并且在乙醇中具有较好的溶解性和溶解速度。

Drugs covered by this patent

Patent Metadata

Patent number
CN103664836B
Jurisdiction
CN
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Qilu (linyi) Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.